Yatin Suneja
Stock Analyst at Guggenheim
(1.57)
# 2,683
Out of 4,814 analysts
124
Total ratings
38.32%
Success rate
-10.03%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals | Reiterates: Buy | n/a | $3.88 | - | 3 | Apr 2, 2025 | |
| CABA Cabaletta Bio | Reiterates: Buy | $23 | $1.17 | +1,865.81% | 3 | Apr 1, 2025 | |
| ZURA Zura Bio | Reiterates: Buy | $15 | $1.37 | +998.90% | 2 | Mar 26, 2025 | |
| IFRX InflaRx | Maintains: Buy | $7 → $10 | $1.10 | +809.09% | 5 | Mar 26, 2025 | |
| LRMR Larimar Therapeutics | Reiterates: Buy | $26 | $2.00 | +1,200.00% | 4 | Mar 25, 2025 | |
| ACET Adicet Bio | Reiterates: Buy | $7 | $0.57 | +1,131.53% | 1 | Mar 21, 2025 | |
| IMVT Immunovant | Reiterates: Buy | n/a | $14.48 | - | 8 | Mar 20, 2025 | |
| DNTH Dianthus Therapeutics | Reiterates: Buy | $84 | $20.45 | +310.76% | 1 | Mar 12, 2025 | |
| ZBIO Zenas BioPharma | Reiterates: Buy | $45 | $9.75 | +361.54% | 3 | Mar 12, 2025 | |
| ARGX argenx SE | Maintains: Buy | $775 → $1,100 | $595.28 | +84.79% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.67 | - | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $163 | $100.68 | +61.90% | 4 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.71 | - | 3 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $9.60 | +368.75% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $14.40 | +38.94% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $36 | $20.60 | +74.76% | 11 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.03 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $16.85 | - | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $13.57 | +379.00% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $170 | $35.34 | +381.04% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,180 → $1,300 | $561.49 | +131.53% | 5 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $4.71 | +579.41% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.78 | - | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $6.34 | +688.64% | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $18.97 | +374.43% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $103.02 | +21.34% | 8 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $10.04 | +59.36% | 2 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $77 | $40.02 | +92.40% | 3 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.71 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $34.64 | +41.45% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $5.90 | +832.20% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $116.58 | +200.22% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.45 | - | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.32 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $12.04 | +99.42% | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $60.11 | -43.44% | 2 | Jan 14, 2020 |
Phathom Pharmaceuticals
Apr 2, 2025
Reiterates: Buy
Price Target: n/a
Current: $3.88
Upside: -
Cabaletta Bio
Apr 1, 2025
Reiterates: Buy
Price Target: $23
Current: $1.17
Upside: +1,865.81%
Zura Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $1.37
Upside: +998.90%
InflaRx
Mar 26, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $1.10
Upside: +809.09%
Larimar Therapeutics
Mar 25, 2025
Reiterates: Buy
Price Target: $26
Current: $2.00
Upside: +1,200.00%
Adicet Bio
Mar 21, 2025
Reiterates: Buy
Price Target: $7
Current: $0.57
Upside: +1,131.53%
Immunovant
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $14.48
Upside: -
Dianthus Therapeutics
Mar 12, 2025
Reiterates: Buy
Price Target: $84
Current: $20.45
Upside: +310.76%
Zenas BioPharma
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $9.75
Upside: +361.54%
argenx SE
Mar 10, 2025
Maintains: Buy
Price Target: $775 → $1,100
Current: $595.28
Upside: +84.79%
Mar 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.67
Upside: -
Feb 10, 2025
Maintains: Buy
Price Target: $165 → $163
Current: $100.68
Upside: +61.90%
Jan 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.71
Upside: -
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $9.60
Upside: +368.75%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $14.40
Upside: +38.94%
Dec 12, 2024
Maintains: Buy
Price Target: $90 → $36
Current: $20.60
Upside: +74.76%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.03
Upside: -
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $16.85
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $13.57
Upside: +379.00%
Aug 14, 2024
Maintains: Buy
Price Target: $155 → $170
Current: $35.34
Upside: +381.04%
Aug 2, 2024
Maintains: Buy
Price Target: $1,180 → $1,300
Current: $561.49
Upside: +131.53%
Jul 23, 2024
Initiates: Buy
Price Target: $32
Current: $4.71
Upside: +579.41%
May 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.78
Upside: -
Apr 29, 2024
Initiates: Buy
Price Target: $50
Current: $6.34
Upside: +688.64%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $18.97
Upside: +374.43%
Feb 21, 2024
Maintains: Buy
Price Target: $110 → $125
Current: $103.02
Upside: +21.34%
Nov 15, 2023
Maintains: Buy
Price Target: $17 → $16
Current: $10.04
Upside: +59.36%
Nov 15, 2023
Maintains: Buy
Price Target: $70 → $77
Current: $40.02
Upside: +92.40%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.71
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $34.64
Upside: +41.45%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $5.90
Upside: +832.20%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $116.58
Upside: +200.22%
Jan 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $7.45
Upside: -
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.32
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $12.04
Upside: +99.42%
Jan 14, 2020
Maintains: Buy
Price Target: $29 → $34
Current: $60.11
Upside: -43.44%